About floatz
Floatz is an AI-powered platform designed to accelerate drug discovery by surfacing high-potential drug targets. Leveraging advanced algorithms, it analyzes complex biological data from genetics, omics, and pathway analysis to identify promising therapeutic targets that might otherwise remain hidden. This enables researchers in biotechnology and life sciences to prioritize the most viable candidates early in the R&D process, reducing time and cost associated with traditional target identification methods.
Focused on the intersection of AI and drug development, floatz supports the entire target identification workflow, from initial data mining to validation. By integrating insights from genomics and pathway analysis, it helps scientists uncover novel connections between diseases and potential interventions. This makes it a valuable tool for pharmaceutical companies and research institutions aiming to streamline their drug discovery pipelines and bring effective therapies to market faster.